• Klobuch S, Weber D, Holler B, Edinger M, Herr W, Holler E, Wolff D., Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience. Ann Hematol. 2019, 98(10):2399-2405. doi: 10.1007/s00277-019-03768-x.
  • Abken H., CAR-T-Zell Therapie hämatologischer Tumoren., TumorDiagn u Ther. 2019; 40, 653 – 657, doi: 10.1055/a-0961-9765 Review.
  • Cheng HW, Onder L, Novkovic M, Soneson C, Lütge M, Pikor N, Scandella E, Robinson MD, Miyazaki JL, Tersteegen A, Sorg U, Pfeffer K, Rülike T, Hehlgans T and Ludewig B., Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp., 2019. Nat Commun. 10: 1-14
  • Ge Y, Böhm HH, Rathinasamy A, Xydia M, Hu X, Pincha M, Umansky L, Breyer C, Hillier M, Bonertz A, Sevko A, Domschke C, Schuetz F, Frebel H, Dettling S, Herold-Mende C, Reissfelder C, Weitz J, Umansky V, Beckhove P., Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer.Cancer Immunol Res. 2019 Dec; 7(12):1998-2012. doi: 10.1158/2326-6066.CIR-18-0763.
  • De Simone G, Mazza EMC, Cassotta A, Davydov AN, Kuka M, Zanon V, De Paoli F, Scamardella E, Metsger M, Roberto A, Pilipow K, Colombo FS, Tenedini E, Tagliafico E, Gattinoni L, Mavilio D, Peano C, Price DA, Singh SP, Farber JM, Serra V, Cucca F, Ferrari F, Orrù V, Fiorillo E, Iannacone M, Chudakov DM, Sallusto F, Lugli E., CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential., J Immunol. 2019 Dec 15; 203(12):3179-3189. doi: 10.4049/jimmunol.1901072.
  • Foell J, Schulte JH, Pfirstinger B, Troeger A, Wolff D, Edinger M, Hoffmann P, Aslanidis C, Lang P, Holler E, Eggert A, Corbacioglu S., Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease., Bone Marrow Transplant. 2019 Nov; 54(11):1859-1867. doi: 10.1038/s41409-019-0550-0.
  • Crauwels P., Bank E., Walber B., Wenzel UA., Agerberth B., Chanyalew M., Abebe M., König R., Ritter U., Reiling N, van Zandbergen G., Cathelicidin Contributes to the Restriction of Leishmania in Human Host Macrophages., Front Immunol., 2019 Nov 22;10:2697.
  • Riegel C, Boeld TJ, Doser K, Huber E, Hoffmann P, Edinger M., Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells., Leukemia. 2019 Nov 12. doi: 10.1038/s41375-019-0625-3.
  • Cossarizza A, Chang HD, Radbruch A,..., Delacher M,..., Edinger M,..., Feuerer M,..., Hoffmann P,..., et al.., Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)., Eur J Immunol. 2019 Oct; 49(10):1457-1973. doi: 10.1002/eji.201970107.
  • Safi S, Yamauchi Y, Stamova S, Rathinasamy A, Op den Winkel J, Jünger S, Bucur M, Umansky L, Warth A, Herpel E, Eichhorn M, Winter H, Hoffmann H, Beckhove P., Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer., Oncoimmunology. 2019 Oct 23; 8(12):e1671762. doi: 10.1080/2162402X.2019.1671762.
  • Schulz D, Streller M, Piendl G, Brockhoff G, Reichert TE, Menevse AN, Beckhove P, Hautmann MG, Bauer RJ, Ettl T., Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma., Carcinogenesis. 2019 Oct 22. pii: bgz177. doi: 10.1093/carcin/bgz177.
  • Hombach AA, Rappl G, Abken H., Blocking CD30 on T cells by a dual specific CAR for CD30 and colon cancer antigens improves the CAR T cell response against CD30 negative tumors., Mol Ther. 2019 Oct 2; 27(10):1825-1835. doi: 10.1016/j.ymthe.2019.06.007.
  • Renner K, Bruss C, Schnell A, Koehl G, Becker HM, Fante M, Menevse AN, Kauer N, Blazquez R, Hacker L, Decking SM, Bohn T, Faerber S, Evert K, Aigle L, Amslinger S, Landa M, Krijgsman O, Rozeman EA, Brummer C, Siska PJ, Singer K, Pektor S, Miederer M, Peter K, Gottfried E, Herr W, Marchiq I, Pouyssegur J, Roush WR, Ong S, Warren S, Pukrop T, Beckhove P, Lang SA, Bopp T, Blank CU, Cleveland JL, Oefner PJ, Dettmer K, Selby M, Kreutz M., Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy., Cell Rep. 2019 Oct 1; 29(1):135-150.e9. doi: 10.1016/j.celrep.2019.08.068.
  • Schick S, Rendeiro AF, Runggatscher K, Ringler A, Boidol B, Hinkel M, Májek P, Vulliard L, Penz T, Parapatics K, Schmidl C, Menche J, Boehmelt G, Petronczki M, Müller AC, Bock C, Kubicek S., Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers., Nat Genet. 2019 Sep; 51(9):1399-1410.
  • Das K, Eisel D, Vormehr M, Müller-Decker K, Hommertgen A, Jäger D, Zörnig I, Feuerer M, Kopp-Schneider A, Osen W, Eichmüller SB., A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice., BMC Cancer. 2019 Sep 13; 19(1):914.
  • Kappelmann-Fenzl M, Gebhard C, Matthies AO, Kuphal S, Rehli M, and Bosserhoff AK., C-Jun drives melanoma progression in PTEN wild type melanoma cells., Cell Death Dis. 2019 Aug 5; 10(8):584. doi: 10.1038/s41419-019-1821-9.
  • Singer K, Dettmer K, Unger P, Schönhammer G, Renner K, Peter K, Siska PJ, Berneburg M, Herr W, Oefner PJ, Karrer S, Kreutz M, Datz E., Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis., Front Oncol. 2019 Jul 3; 9:605.
  • Hamdane N, Jühling F, Crouchet E, El Saghire H, Thumann C, Oudot MA, Bandiera S, Saviano A, Ponsolles C, Roca Suarez AA, Li S, Fujiwara N, Ono A, Davidson I, Bardeesy N, Schmidl C, Bock C, Schuster C, Lupberger J, Habersetzer F, Doffoël M, Piardi T, Sommacale D, Imamura M, Uchida T, Ohdan H, Aikata H, Chayama K, Boldanova T, Pessaux P, Fuchs BC, Hoshida Y, Zeisel MB, Duong FHT, Baumert TF., HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response., Gastroenterology. 2019 Jun; 156(8):2313-2329.e7. doi: 10.1053/j.gastro.2019.02.038.
  • Sdelci S, Rendeiro AF, Rathert P, You W, Lin JG, Ringler A, Hofstätter G, Moll HP, Gürtl B, Farlik M, Schick S, Klepsch F, Oldach M, Buphamalai P, Schischlik F, Májek P, Parapatics K, Schmidl C, Schuster M, Penz T, Buckley DL, Hudecz O, Imre R, Wang SY, Maric HM, Kralovics R, Bennett KL, Müller AC, Mechtler K, Menche J, Bradner JE, Winter GE, Klavins K, Casanova E, Bock C, Zuber J, Kubicek S., MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation., Nat Genet. 2019 Jun; 51(6):990-998.
  • Hartley J, Abken H., Chimeric antigen receptors designed to overcome TGF-β mediated repression in the adoptive T cell therapy of solid tumors., Clin Transl Immunology. 2019 Jun 22; 8(6):e1064. doi: 10.1002/cti2.1064. Review.
  • Balam S, Schiechl-Brachner G, Buchtler S, Halbritter D, Schmidbauer K, Talke Y, Neumayer S, Salewski JN, Winter F, Karasuyama H, Yamanishi Y, Renner K, Geissler EK, Mack M., IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils., J Immunol. 2019 Jun 15; 202(12):3514-3523. doi: 10.4049/jimmunol.1801269.
  • Chmielewski M, Kühle J, Chrobok D, Riet N, Hallek M, Abken H., FimH-based display of functional eukaryotic proteins on bacteria surfaces., Scientific Reports, 2019 Jun 10; 9(1):8410. doi: 10.1038/s41598-019-44883-z.
  • Ribechini E., Eckert I., Beilhack A., Du Plessis N., Walz G., Schleicher U., Ritter U.,Lutz M.B., Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability., JCI Insight. 2019 Jun 4; 5. pii: 128664. doi: 10.1172/jci.insight.128664.
  • Schmidleithner L, Thabel Y, Schhönfeld E, Köhne M, Sommer D, Abdullah Z, Sadlon t, Osei-Sarpong C, Subbaramaiah K, copperi F, Haendler K, Varga T, Schanz o, Bourry S, Bassler K, Krebs W, Peters AE, Baumgart AK, Schneeweiss M, Klee K, Schmidt SV, Nüssing S, Sander J, Ohkura N, Waha A, Sparwasser t, Wunderlich FT, Förster I, Ulas T, Weighardt H, Sakaguchi S, Pfeifer A, Blüher M, Dannenberg AJ, Ferreirós N, Muglia LJ, Wickenhauser C, Barry SC, Schultze JL, Beyer M., Enzymatic Activity of HPGD in Treg Cels Suppresses Tcony Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction.Immunity., 2019 May 21;50(5):1232-1248e14. doi: 10.1016/jimmuni.2019.03.014.
  • Delacher M, Schmidl C, Herzig Y, Breloer M, Hartman W, Brunk F, Kägebein D, Träger U, Hofer AC, Bittner S, Weichenhan D, Imbusch CD, Hotz-Wagenblatt A, Hielscher T, Breiling A, Federico G, Gröne HJ, Schmid RM, Rehli M, Abramson J, Feuerer M., RBPJ expression in regulatory T cells is critical for restraining TH2 responses., Nature Communications, 2019 Apr 8; 10(1):1621.
  • Schmidl C, Vladimer GI, Rendeiro AF, Schnabl S, Krausgruber T, Taubert C, Krall N, Pemovska T, Araghi M, Snijder B, Hubmann R, Ringler A, Runggatscher K, Demirtas D, de la Fuente OL, Hilgarth M, Skrabs C, Porpaczy E, Gruber M, Hoermann G, Kubicek S, Staber PB, Shehata M, Superti-Furga G, Jäger U, Bock C., Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL., Nat Chem Biol. 2019 Mar; 15(3):232-240. doi: 10.1038/s41589-018-0205-2.
  • Riquelme P, Geissler EK, Hutchinson JA., C5aR1 governs Mreg migration, development, and function., Am J Transplant. 2019 Mar; 19(3):619-621. doi: 10.1111/ajt.15153.
  • Hoffmeister H, Fuchs A, Strobl L, Sprenger F, Gröbner-Ferreira R, Michaelis S, Hoffmann P, Nazet J, Merkl R, Längst G., Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1., J Biol Chem. 2019 Mar 1; 294(9):3294-3310. doi: 10.1074/jbc.RA118.005685.
  • Werner-Klein M, Klein CA., Therapy resistance beyond cellular dormancy., Nat Cell Biol. 2019 Feb; 21(2):117-119.
  • Aleksandrova K, Leise J, Priesner C, Melk A, Kubanik F, Abken H, Hombach A, Murat A, Mike E, Bürger I, Kaiser A, Rauser G, Jurk M, Goudeva L, Glienke W, Arseniev L, Ruth E, Köhl U., Functionality and cell senescence of CD4/CD8-selected CD20 CAR T cells manufactured using the automated CliniMACS Prodigy® platform., Transfus Med Hemother. 2019 Feb; 46(1):47-54. doi: 10.1159/000495772. Review.
  • Ten Brinke A, Martinez-Llordella M, Cools N, Hilkens CMU, van Ham SM, Sawitzki B, Geissler EK, Lombardi G, Trzonkowski P, Martinez-Caceres E., Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective., Front Immunol. 2019 Feb 22; 10:181. doi: 10.3389/fimmu.2019.00181. Review.
  • Ugele I, Cárdenas-Conejo ZE, Hammon K, Wehrstein M, Bruss C, Peter K, Singer K, Gottfried E, Boesch J, Oefner P, Dettmer K, Renner K, Kreutz M., D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells., Int J Mol Sci. 2019 Feb 10; 20(3).
  • Holzinger A, Abken H., CAR T cells: a snapshot on the growing options to design a CAR. Hemasphere., 2019 Feb 1; 3(1):e172. doi: 10.1097/HS9.0000000000000172. Review.
  • Gebhard C, Glatz D, Schwarzfischer L, Wimmer J, Stasik S, Nuetzel M, Heudobler D, Andreesen R, Ehninger G, Thiede C, Rehli M., Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association., Leukemia. 2019 Jan; 33(1):26-36. doi: 10.1038/s41375-018-0165-2.
  • Stieglitz D, Lamm S, Braig S, Feuerer L, Kuphal S, Dietrich P, Arndt S, Echtenacher B, Hellerbrand C, Karrer S, Bosserhoff AK., BMP6-induced modulation of the tumor micro-milieu., Oncogene. 2019 Jan; 38(5):609-621. doi: 10.1038/s41388-018-0475-x.
  • Boscheinen JB, Thomann S, Knipe DM, DeLuca N, Schuler-Thurner B, Gross S, Dörrie J, Schaft N, Bach C, Rohrhofer A, Werner-Klein M, Schmidt B, Schuster P., Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA., Front Immunol. 2019 Jan 22; 10:2.
  • Gustafsson C, De Paepe A, Schmidl C, Månsson R., High-throughput ChIPmentation: freely scalable, single day ChIPseq data generation from very low cell-numbers., BMC Genomics. 2019 Jan 18; 20(1):59.
  • Schulz D, Stancev I, Sorrentino A, Menevse AN, Beckhove P, Brockhoff G, Hautmann MG, Reichert TE, Bauer RJ, Ettl T., Increased PD-L1 expression in radioresistant HNSCC cell lines after irradiation affects cell proliferation due to inactivation of GSK-3beta., Oncotarget. 2019 Jan 15; 10 (5):573-583. doi: 10.18632/oncotarget.26542.
Anfahrt